HIGHLIGHTS
- What: This study provides complete information about thyroid cancer drivers. The pediatric group was excluded because the study was not designed to detect gene fusions. An important reason for this was that the panel in the study was not designed for gene fusion and other rearrangement detection. In the study, considering cost-effectiveness, a non-specific and solely DNA-based next-generation sequencing technique was used.
- Who: Pathologically Diagnosed as Indeterminate and colleagues from the Ege University School of Medicine have published the Article: Next Generation Sequence-Based Targeted Somatic Mutation Analysis in Thyroid Nodules . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.